口服型凝血酶直接抑制剂希美加群与标准疗法治疗急性深静脉血栓形成的随机、对照、剂量指导性比较研究

• A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I